These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3289162)

  • 1. Kidney graft survival in sensitized, cyclosporine A-treated recipients in Scandiatransplant.
    Jacobsen SE; Fjeldborg O; Madsen M; Lamm LU
    Transplant Proc; 1988 Jun; 20(3):365-6. PubMed ID: 3289162
    [No Abstract]   [Full Text] [Related]  

  • 2. A past positive crossmatch does not affect allograft survival for cyclosporine-immunosuppressed primary and secondary renal transplant recipients.
    Quinn T; Louis P; Mallis M; Senitzer DS; Tellis V; Matas A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):704. PubMed ID: 2650232
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal allograft survival in highly sensitized patients treated with cyclosporine.
    Doran M; Coppage M; Ruth J; Fish J; Winsett O; Vaidya S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1988. PubMed ID: 3274458
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine improves outcome in high-risk cadaveric renal allograft recipients.
    Van Buren CT; Flechner SM; Kerman RH; Vaughn W; Kahan BD
    Transplant Proc; 1984 Oct; 16(5):1162-6. PubMed ID: 6385365
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors of outcome in cyclosporine-treated recipients of second renal transplants.
    Merion RM; Campbell DA; Dafoe DC; Rosenberg L; Rocher LL; Turcotte JG
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):194-7. PubMed ID: 3291240
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
    Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H
    Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine A and histocompatibility in kidney transplantation.
    Cook DJ; Terasaki PI
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):244-8. PubMed ID: 3291250
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival of cadaveric donor renal allografts in cyclosporine A-treated recipients: the influence of HLA-DR antigen matching.
    Madsen M; Fjeldborg O; Graugaard B; Posborg V; Kissmeyer-Nielsen F
    Transplant Proc; 1988 Jun; 20(3):369-71. PubMed ID: 3381251
    [No Abstract]   [Full Text] [Related]  

  • 10. Kidney transplantation in sensitized patients.
    Opelz G
    Transplant Proc; 1987 Oct; 19(5):3737-41. PubMed ID: 3313904
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of HLA matching in cadaver renal transplants.
    Najarian JS; Migliori RJ; Simmons RL; Ascher NL; Payne WD; Dunn D; Sutherland DE; Fryd DS
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):249-56. PubMed ID: 3291251
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and experimental studies with cyclosporine in renal transplantation.
    Kahan BD; van Buren CT; Flechner SM; Jarowenko M; Yasumura T; Rogers AJ; Yoshimura N; LeGrue S; Drath D; Kerman RH
    Surgery; 1985 Feb; 97(2):125-40. PubMed ID: 3881837
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine therapy and other adjuncts in the perioperative period with cadaveric and living related donor kidney transplantation.
    Milgrom M; Esquenazi V; Olson L; Fuller L; Roth D; Condie R; Kyriakides G; Miller J
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):8-11. PubMed ID: 3515699
    [No Abstract]   [Full Text] [Related]  

  • 14. Pre-transplant transfusions in renal recipients treated with cyclosporine: a subject of controversy.
    Ortuño J; Pelaez E; Teruel JL; Orte L; Marcén R; Felipe C; Matesanz R; Quereda C
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):70-2. PubMed ID: 3051595
    [No Abstract]   [Full Text] [Related]  

  • 15. What I needed to know about cyclosporine.
    Li JT
    N C Med J; 1984 Dec; 45(12):771-2. PubMed ID: 6392894
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine use in early graft dysfunction.
    Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):104-12. PubMed ID: 3515675
    [No Abstract]   [Full Text] [Related]  

  • 17. Care of the renal transplant patient receiving cyclosporine.
    Oyler-Mooney J; Taylor S; Ulrich B
    J Nephrol Nurs; 1985; 2(6):274-6. PubMed ID: 3908647
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal replacement therapy in the cyclosporine era: results of a national transplantation program.
    Albrechtsen D; Berg KJ; Brekke I; Fauchald P; Jakobsen A; Sødal G; Talseth T; Leivestad T; Flatmark A
    Transplant Proc; 1990 Feb; 22(1):155-6. PubMed ID: 2309295
    [No Abstract]   [Full Text] [Related]  

  • 19. The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine.
    Smith AY; Van Buren CT; Lewis RM; Kerman RH; Welsh M; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):180-93. PubMed ID: 3291239
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate.
    Tollemar J; Ringdén O; Sundberg B; Bolme P; Brattström C; Gahrton G; Johansen L; Lönnqvist B
    Transplant Proc; 1988 Jun; 20(3):494-8. PubMed ID: 3381257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.